TruBridge Market Cap

TruBridge has a market cap or net worth of $116.64 million as of April 26, 2024. Its market cap has decreased by -71.77% in one year.

Market Cap

116.64M

Enterprise Value

311.15M

1-Year Change

-71.77%

Ranking

#4009

Market Cap Chart

Since May 21, 2002, TruBridge's market cap has decreased from $190.00M to $116.64M, a decrease of -38.61%. That is a compound annual growth rate of -2.20%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	113.90M	-0.87%
Apr 24, 2024	114.90M	-2.13%
Apr 23, 2024	117.40M	-1.76%
Apr 22, 2024	119.50M	-0.42%
Apr 19, 2024	120.00M	2.13%
Apr 18, 2024	117.50M	-2.57%
Apr 17, 2024	120.60M	-0.41%
Apr 16, 2024	121.10M	-2.34%
Apr 15, 2024	124.00M	-2.75%
Apr 12, 2024	127.50M	-1.92%
Apr 11, 2024	130.00M	-0.54%
Apr 10, 2024	130.70M	-1.13%
Apr 9, 2024	132.20M	0.76%
Apr 8, 2024	131.20M	1.94%
Apr 5, 2024	128.70M	6.63%
Apr 4, 2024	120.70M	-2.03%
Apr 3, 2024	123.20M	-3.30%
Apr 2, 2024	127.40M	4.26%
Apr 1, 2024	122.20M	-8.67%
Mar 28, 2024	133.80M	-3.53%
Mar 27, 2024	138.70M	5.16%
Mar 26, 2024	131.90M	-3.30%
Mar 25, 2024	136.40M	1.11%
Mar 22, 2024	134.90M	-1.82%
Mar 21, 2024	137.40M	-1.22%

View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
InterCure	118.49M
Xtant Medical Holdings	118.37M
GlycoMimetics	118.27M
Relmada Therapeutics	117.98M
PDS Biotechnology	117.37M
Seer, Inc.	117.24M
Nuvectis Pharma	117.10M
Adagene	116.91M

Market Cap Rankings